and Disqualification Recommendations for Competitive Athletes With
Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for
Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the
American Heart Association and American College of Cardiology

Barry J. Maron, Benjamin D. Levine,
Reginald L. Washington, Aaron L. Baggish, Richard J. Kovacs, Martin S. Maron,
and on behalf of the American Heart Association Electrocardiography and
Arrhythmias Committee of the Council on Clinical Cardiology, Council on
Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke
Nursing, Council on Functional Genomics and Translational Biology, and the
American College of Cardiology
Circulation. 2015; published online
before print November 2 2015, doi:10.1161/CIR.0000000000000238
The American Heart Association and
American College of Cardiology have released a series of scientific statements
regarding eligibility and disqualification recommendation for competitive
athletes with cardiovascular abnormalities. This is the 3rd document of 15
scientific statements. This one discusses preparticipation screening for
cardiovascular disease in competitive athletes. It concludes with 5